Nanobiotix

Nanobiotix
Stock Exchange Euronext Paris
EPS
EUR1.54
Market Cap
EUR221.43 M
Shares Outstanding
22.2 M
Public Float
18.96 M

Profile

Address
60, rue de Wattignies
Paris Ile-de-France 75012
France
Employees -
Website http://www.nanobiotix.com
Updated 07/08/2019
Nanobiotix SA engages in the development of nanoparticle-based technologies for the treatment of cancer. The company's technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. It also engages in the development of magnetic particles and laser activated nanoparticles for the treatment and diagnosis of cancer.

Financials

View All

Laurent Condomine
Chairman-Supervisory Board
Enno Spillner
Member-Supervisory Board